XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.24.3

Goodwill and Other Intangible Assets, Net Goodwill and Other Intangible Assets, Net (Notes) | 9 Months Ended
--- | ---
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Other Intangible Assets, Net | GOODWILL AND OTHER INTANGIBLE ASSETS, NET Goodwill Movements in goodwill attributable to each reportable segment for the nine months ended September 30, 2024 were as follows:
(DOLLARS IN MILLIONS) | Nourish |  | Health & Biosciences |  | Scent |  | Pharma Solutions |  |  |  | Total
Balance at January 1, 2024 | $ | 3,489 |  |  | $ | 4,391 |  |  | $ | 1,490 |  |  | $ | 1,265 |  |  |  |  | $ | 10,635 |
Transferred to assets held for sale(1) | (55) |  |  | — |  |  | — |  |  | (1,248) |  |  |  |  | (1,303) |
Reduction from business divestitures(2) | (10) |  |  | — |  |  | — |  |  | — |  |  |  |  | (10) |
Foreign exchange | 20 |  |  | 20 |  |  | 4 |  |  | (17) |  |  |  |  | 27 |
Balance at September 30, 2024 | $ | 3,444 |  |  | $ | 4,411 |  |  | $ | 1,494 |  |  | $ | — |  |  |  |  | $ | 9,349 |
_______________________ (1)Recognized $64 million of impairment related to the Pharma Solutions disposal group classified as held for sale as of September 30, 2024. See Note 3 for additional information. (2)Relates to the divestiture of the Flavors & Essences UK business. See Note 3 for additional information. The goodwill balances at January 1, 2024 and September 30, 2024 included $2.623 billion and $2.250 billion of accumulated impairment related to the Nourish and Health & Biosciences reportable segments. The accumulated impairment relates to impairment charges recorded in 2023 and 2022. Other Intangible Assets Other intangible assets, net consisted of the following amounts:
| September 30, |  | December 31,
(DOLLARS IN MILLIONS) | 2024 |  | 2023
Asset Type |  |  |
Customer relationships | $ | 7,209 |  |  | $ | 8,211 |
Technological know-how | 1,992 |  |  | 2,355 |
Trade names & patents | 277 |  |  | 337 |
Other | 25 |  |  | 44 |
Total carrying value | 9,503 |  |  | 10,947 |
Accumulated Amortization |  |  |
Customer relationships | (1,733) |  |  | (1,619) |
Technological know-how | (853) |  |  | (813) |
Trade names & patents | (126) |  |  | (117) |
Other | (21) |  |  | (41) |
Total accumulated amortization | (2,733) |  |  | (2,590) |
Other intangible assets, net | $ | 6,770 |  |  | $ | 8,357 |
Amortization Amortization expense was $146 million and $170 million for the three months ended September 30, 2024 and 2023, respectively, and $467 million and $513 million for the nine months ended September 30, 2024 and 2023, respectively. Amortization expense for the next five years, based on valuations and determinations of useful lives, is expected to be as follows:
(DOLLARS IN MILLIONS) | Remainder of 2024 |  | 2025 |  | 2026 |  | 2027 |  | 2028
Estimated future intangible amortization expense | $ | 146 |  |  | $ | 583 |  |  | $ | 580 |  |  | $ | 493 |  |  | $ | 480 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration